Vanguard Group’s Contineum Therapeutics CTNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.95M | Sell |
744,001
-59,427
| -7% | -$236K | ﹤0.01% | 3389 |
|
|
2025
Q1 | $5.61M | Sell |
803,428
-5,655
| -0.7% | -$39.5K | ﹤0.01% | 3123 |
|
|
2024
Q4 | $11.9M | Buy |
809,083
+347,756
| +75% | +$5.09M | ﹤0.01% | 2861 |
|
|
2024
Q3 | $8.83M | Sell |
461,327
-10,290
| -2% | -$197K | ﹤0.01% | 3019 |
|
|
2024
Q2 | $8.31M | Buy |
+471,617
| New | +$8.31M | ﹤0.01% | 3025 |
|